服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Application | Isotype |
| Anti-ITGAL/CD11A/LFA1A and ITGB2/CD18 mAbs [Rovelizumab Biosimilar] (MABL-5193) | MABL-5193 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-FCGRT/FcRn mAbs [Rozanolixizumab Biosimilar] (MABL-5194) | MABL-5194 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-ICOS/CD278 mAbs [Rozibafusp Biosimilar] (MABL-5195) | MABL-5195 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Rulonilimab Biosimilar] (MABL-5196) | MABL-5196 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ERBB2/CD340/HER2;CD3E mAbs [Runimotamab Biosimilar] (MABL-5197) | MABL-5197 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-PDCD1/CD279/PD1;TIGIT/WUCAM/VSTM3 mAbs [Rilvegostomig Biosimilar] (MABL-5171) | MABL-5171 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Lambda |
| Anti-SARS-CoV-2 Spike RBD mAbs [Rimteravimab Biosimilar] (MABL-5172) | MABL-5172 | ELISA, FACS, Functional assay, in vivo binding | G1, na |
| Anti-FOLR1 mAbs [Rinatabart Biosimilar] (MABL-5173) | MABL-5173 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDGFRB/CD140B mAbs [Rinucumab Biosimilar] (MABL-5174) | MABL-5174 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-MS4A1/CD20 mAbs [Ripertamab Biosimilar] (MABL-5175) | MABL-5175 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL23A mAbs [Risankizumab Biosimilar] (MABL-5176) | MABL-5176 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MS4A1/CD20 mAbs [Rituximab Biosimilar] (MABL-5177) | MABL-5177 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PcrV type III secretion system mAbs [Rivabazumab Biosimilar] (MABL-5178) | MABL-5178 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IGF1R/CD221 mAbs [Robatumumab Biosimilar] (MABL-5179) | MABL-5179 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF4/CD134/OX40 mAbs [Rocatinlimab Biosimilar] (MABL-5180) | MABL-5180 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL17A mAbs [Roconkibart Biosimilar] (MABL-5181) | MABL-5181 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-RhD/CD240D/RhPI mAbs [Roledumab Biosimilar] (MABL-5182) | MABL-5182 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PRLR mAbs [Rolinsatamab Biosimilar] (MABL-5183) | MABL-5183 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-LILRB4/CD85K mAbs [Rolistobart Biosimilar] (MABL-5184) | MABL-5184 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PVRIG/NECTIN2 receptor/CD112R mAbs [Remzistotug Biosimilar] (MABL-5156) | MABL-5156 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn